Targeting a Pathogenic Variant Creating an Upstream AUG in the ENG 5' Untranslated Region with Antisense Oligonucleotides Fails to Restore Protein Expression.

IF 4.5 2区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Nucleic acid therapeutics Pub Date : 2026-02-01 Epub Date: 2026-01-07 DOI:10.1177/21593337251396711
Mathilde Doisy, Aris Gaci, Omar Soukarieh, Carole Proust, David-Alexandre Trégouët, Aurélie Goyenvalle
{"title":"Targeting a Pathogenic Variant Creating an Upstream AUG in the <i>ENG</i> 5' Untranslated Region with Antisense Oligonucleotides Fails to Restore Protein Expression.","authors":"Mathilde Doisy, Aris Gaci, Omar Soukarieh, Carole Proust, David-Alexandre Trégouët, Aurélie Goyenvalle","doi":"10.1177/21593337251396711","DOIUrl":null,"url":null,"abstract":"<p><p>Pathogenic variants creating upstream open reading frames (uORFs) in the 5' untranslated region (5'UTR) of the <i>ENG</i> gene can disrupt translation from the main ORF and contribute to hereditary hemorrhagic telangiectasia (HHT). This is the case of the <i>ENG</i> c.-79C>T that introduces a uAUG shown to decrease endoglin expression and associates with HHT. Here, we investigated whether 2'-O-methyl (2'OMe) antisense oligonucleotides (ASOs) could restore protein levels by masking this aberrant uAUG or by targeting predicted secondary structures within the <i>ENG</i> 5'UTR. Several ASOs of varying lengths and backbone chemistries (full phosphodiester or full phosphorothioate) were designed to target the mutant region. Their effects were evaluated in HeLa cells transfected and in HUVECs transduced with wild-type or mutant <i>ENG</i> constructs. Transfection efficiency was verified by <i>MALAT1</i> knockdown via qPCR, and endoglin protein levels were assessed by Western blot. Despite efficient ASO delivery and optimized experimental conditions, no reproducible increase in endoglin expression was observed upon ASO treatment. These findings highlight the limitations of steric-blocking ASOs targeting 5'UTR variants and underscore the need for deeper mechanistic understanding of uORF-mediated translational regulation.</p>","PeriodicalId":19412,"journal":{"name":"Nucleic acid therapeutics","volume":" ","pages":"12-22"},"PeriodicalIF":4.5000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nucleic acid therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/21593337251396711","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Pathogenic variants creating upstream open reading frames (uORFs) in the 5' untranslated region (5'UTR) of the ENG gene can disrupt translation from the main ORF and contribute to hereditary hemorrhagic telangiectasia (HHT). This is the case of the ENG c.-79C>T that introduces a uAUG shown to decrease endoglin expression and associates with HHT. Here, we investigated whether 2'-O-methyl (2'OMe) antisense oligonucleotides (ASOs) could restore protein levels by masking this aberrant uAUG or by targeting predicted secondary structures within the ENG 5'UTR. Several ASOs of varying lengths and backbone chemistries (full phosphodiester or full phosphorothioate) were designed to target the mutant region. Their effects were evaluated in HeLa cells transfected and in HUVECs transduced with wild-type or mutant ENG constructs. Transfection efficiency was verified by MALAT1 knockdown via qPCR, and endoglin protein levels were assessed by Western blot. Despite efficient ASO delivery and optimized experimental conditions, no reproducible increase in endoglin expression was observed upon ASO treatment. These findings highlight the limitations of steric-blocking ASOs targeting 5'UTR variants and underscore the need for deeper mechanistic understanding of uORF-mediated translational regulation.

用反义寡核苷酸靶向在eng5 '非翻译区上游制造AUG的致病变异未能恢复蛋白表达。
在ENG基因的5‘非翻译区(5’ utr)产生上游开放阅读框(uorf)的致病变异可以破坏主要ORF的翻译,并导致遗传性出血性毛细血管扩张(HHT)。这是ENG c.-79C>T的病例,该病例引入了一种可降低内啡肽表达并与HHT相关的uAUG。在这里,我们研究了2'- o -甲基(2' ome)反义寡核苷酸(ASOs)是否可以通过掩盖这种异常的uAUG或靶向ENG 5'UTR内预测的二级结构来恢复蛋白质水平。设计了几种不同长度和骨架化学成分(全磷酸二酯或全硫代磷酸)的ASOs来靶向突变区域。在转染的HeLa细胞和用野生型或突变型ENG构建体转导的HUVECs中评估了它们的作用。通过qPCR敲低MALAT1验证转染效率,Western blot检测内啡肽蛋白水平。尽管ASO有效地给药并优化了实验条件,但在ASO治疗后,内啡肽的表达并未出现可重复的增加。这些发现强调了靶向5'UTR变异的立体阻断ASOs的局限性,并强调了对uorf介导的翻译调控进行更深入的机制理解的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nucleic acid therapeutics
Nucleic acid therapeutics BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
CiteScore
7.60
自引率
7.50%
发文量
47
审稿时长
>12 weeks
期刊介绍: Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书